XNCR Stock Analysis: Buy, Sell, or Hold?
XNCR - Xencor, Inc.
$12.09
-0.29 (-2.34%)
▼
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
24d
Get Alerted When XNCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XNCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XNCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XNCR is currently trading at $12.09, which is considered oversold relative to its 30-day fair value range of $12.82 to $14.94.
Technical Outlook: Technically, XNCR is in a uptrend. The price is currently testing key support at $11.82. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: XNCR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $28.83 (+138.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XNCR is in a uptrend. The price is currently testing key support at $11.82. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: XNCR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $28.83 (+138.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$12.82 -
$14.94
Company Quality Score
50/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
Protect Your Profits
Holding XNCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 138.5% below Wall St target ($28.83)
- CAUTION: Recommendation downgraded due to -5.4% 5-day decline
Fair Price Analysis
30-Day Fair Range
$12.82 -
$14.94
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$1.14
(9.4%)
Support & Resistance Levels
Support Level
$11.82
Resistance Level
$13.75
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.61
Wall Street Target
$28.83
(+138.5%)
Revenue Growth (YoY)
18.0%
Profit Margin
-87.1%
Last updated: January 31, 2026 11:19 PM ET
Data refreshes hourly during market hours. Next update: 12:19 AM
Data refreshes hourly during market hours. Next update: 12:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XNCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced XNCR Option Strategies
Professional options setups generated by AI based on today's XNCR price and gamma walls.
